Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study

M. Chaparro, A. Verreth, T. Lobaton, E. Gravito-Soares, M. Julsgaard, E. Savarino, F. Magro, I.A. Biron, P. Lopez-Serrano, M.J. Casanova, M. Gompertz, S. Vitor, M. Arroyo, D. Pugliese, Y. Zabana, R. Vicente, M. Aguas, A.B.-G. Shitrit, A. Gutierrez, G.A. DohertyL. Fernandez-Salazar, J.M. Cadilla, J.M. Huguet, A. O’Toole, E. Stasi, N.M. Marcos, A. Villoria, K. Karmiris, J.F. Rahier, C. Rodriguez, M. Diz-Lois Palomares, G. Fiorino, J.M. Benitez, M. Principi, T. Naftali, C. Taxonera, G. Mantzaris, L. Sebkova, B. Iade, D. Lissner, I.F. Bradley, A.L.-S. Roman, I. Marin-Jimenez, O. Merino, M. Sierra, M. Van Domselaar, F. Caprioli, I. Guerra, P. Peixe, M. Piqueras, I. Rodriguez-Lago, Y. Ber, K. van Hoeve, P. Torres, M. Gravito-Soares, D. Rudbeck-Resdal, O. Bartolo, A. Peixoto, G. Martin, A. Armuzzi, A. Garre, M.G. Donday, F.J. Martín de Carpi, J.P. Gisbert

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study'. Together they form a unique fingerprint.

Medicine & Life Sciences